Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model - Wikidata - awgldk - TriplyDB

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

http://www.wikidata.org/entity/Q33953399

about

In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Hyaluronan and cardiac regeneration The extracellular microscape governs mesenchymal stem cell fate.Physiological Implications of Myocardial Scar Structure Why Is Infarct Expansion Such an Elusive Therapeutic Target?Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine Biomedical Applications of Biodegradable Polymers.Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition Experimental and computational investigation of altered mechanical properties in myocardium after hydrogel injection.Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.Increased infarct wall thickness by a bio-inert material is insufficient to prevent negative left ventricular remodeling after myocardial infarction.Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium.Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair.Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodeling Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1α angiogenic therapy for acute myocardial infarction in a murine model.Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia Infarct restraint to limit adverse ventricular remodeling.Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.Injectable microsphere gel progressively improves global ventricular function, regional contractile strain, and mitral regurgitation after myocardial infarction.Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.A novel method for quantifying the in-vivo mechanical effect of material injected into a myocardial infarction.Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges.Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling Modification of infarct material properties limits adverse ventricular remodeling.Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.MRI evaluation of injectable hyaluronic acid-based hydrogel therapy to limit ventricular remodeling after myocardial infarction.Reprogramming cardiomyocyte mechanosensing by crosstalk between integrins and hyaluronic acid receptors.Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking.Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough?Hyaluronic acid-human blood hydrogels for stem cell transplantation.Shear-Thinning Supramolecular Hydrogels with Secondary Autonomous Covalent Crosslinking to Modulate Viscoelastic Properties In Vivo.Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats.Intramyocardial injection of hydrogel with high interstitial spread does not impact action potential propagation Optimized local infarct restraint improves left ventricular function and limits remodeling.Moderate Ischemic Mitral Regurgitation After Posterolateral Myocardial Infarction in Sheep Alters Left Ventricular Shear but Not Normal Strain in the Infarct and Infarct Borderzone.Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment

P2860

Q26775715-3F87211C-73F0-443D-B9CA-FB3A6BECDE15 Q26852190-3307A25F-CA68-464A-8101-87B9DD6B0506 Q28073455-8A2C19E6-78F2-4C5B-A796-0EEDE7B6C7E4 Q28085424-F570DEDD-B711-43CB-991D-A9ADC019086B Q30278655-278FE5B5-8F8E-42D3-A58B-85AEB042E166 Q30390768-500686B6-79BA-44F0-864E-D15062C922DF Q30426452-56613B4F-F9D7-437D-935A-2ED79F983D5F Q30596582-5DE908A6-CF63-4C4A-9310-73D3EC9594B8 Q33650887-154CA48C-9FB0-4DB9-B793-90505E2FE08C Q33655418-CE8CD07E-1E39-46E6-9BB6-5F8F329003F8 Q33951374-C94CA3FC-5222-4657-B354-5DCEB6436DB7 Q33952558-F4C124FD-3E96-4372-89DD-50EBA3C34762 Q34035670-8F4D9E5D-CC53-46AA-A78A-2CAEC8C55BE8 Q34050245-13127306-E45D-4B9E-B0C7-CE361272BBA0 Q34104323-33C81773-BF9A-4237-9315-2B9A48F83554 Q34109419-E9F0A3E5-1CB1-44F2-811B-B51C3D7377B9 Q34125089-564D85BA-EC97-432E-A8E5-43C62C052C9C Q34140398-6DEB0FFF-2D8C-4617-B39E-88D60E1913DA Q34218250-28F3BA89-262D-43C4-9561-CAE66234A9E9 Q34491735-6B2CEF33-FE6E-4E6A-90B2-CBE2681B9C62 Q34531894-E885EF18-28C1-493A-962A-5A9DFDBE115F Q34772618-A2EF60A7-9DE9-49B3-B973-B10DB0880550 Q35039708-08BA6E7D-ED92-4B82-94F9-4E39749A1924 Q35194787-485B2FAA-6A79-442D-92D6-3969DA9A1CD3 Q35250109-D57DDCDA-DEDF-41DF-9A0F-F160C581FCC7 Q35524961-699ED935-EC4C-4C2B-8D49-F8015BC87FC6 Q35634564-9A9CDB1E-BC91-4427-BEF0-5DD18F40B691 Q35662201-74B41515-E966-4F8C-B89B-D8B3918B6C60 Q35774342-4EAB95B8-2079-41F8-8D9D-020DDC35AF55 Q36016748-E942AA42-B5F8-4645-9A6A-728829A0E3C4 Q36068390-CD869320-90B2-4F42-82EB-5C04D8DD86DA Q36128346-0BDC8F0A-AD22-480D-B69C-569634D16603 Q36188261-C38F6D79-C470-4454-8376-42A66BACF8B0 Q36203341-68283FE1-0336-4721-A40E-75B2F58B6765 Q36219544-E2431ED1-1746-46A8-B0FB-AA92D51042AF Q36437704-5429A145-A072-42DE-9D77-412CD7701EFD Q36635288-817D0067-8005-47C0-8A78-D53751467B39 Q36713882-AA351067-9038-4823-9950-6C4DDB705AE9 Q36828360-97F75220-041D-4C50-A5D9-2BE4DD20D602 Q36893273-B554179F-F0FE-48CC-A4BA-AC0F637374B9

P2860

Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model

http://www.wikidata.org/entity/Q33953399

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Injectable hydrogel properties ...... r remodeling in an ovine model

@ast

Injectable hydrogel properties ...... r remodeling in an ovine model

@en

type

label

Injectable hydrogel properties ...... r remodeling in an ovine model

@ast

Injectable hydrogel properties ...... r remodeling in an ovine model

@en

prefLabel

Injectable hydrogel properties ...... r remodeling in an ovine model

@ast

Injectable hydrogel properties ...... r remodeling in an ovine model

@en

P1433

Q33953399-CC9ED00B-1183-4ABD-A6F9-A89F24252338

P1476

Q33953399-382232CB-8A92-4458-9DC0-B301F3334F57

P2093

Q33953399-0F0E17AA-B3C0-4D22-9F1C-8D0BB59C8022

Q33953399-214F15A7-914B-4A33-8523-B110F2E01947

Q33953399-2CBCE55C-828E-44C2-97DF-2EAD5AC9BBCE

Q33953399-50CFB76B-D592-4789-84FE-C9F3A17A6E3F

Q33953399-586E0F3D-12BD-4BE8-A4D4-0EDA359E22FD

Q33953399-6AE60538-2ACC-4CCA-B71B-E1924720762E

Q33953399-83E5FC1B-E478-465C-B674-C3C03C89E00A

Q33953399-9954CD2F-C50C-4E95-90AE-550F3F73118F

Q33953399-AE05BAF3-DD31-4861-8A37-BE0A6EA8CCD5

P2860

Q33953399-0AB890FB-23A6-46EE-A550-123BA7AADBA7

Q33953399-124B4F2D-3675-4AFC-961F-E5F1AA543AC3

Q33953399-1B19F631-0359-4854-B99D-3498CE92ED58

Q33953399-20E0E040-BF88-465D-A9A5-3BADCC75F441

Q33953399-2925A31E-835F-46A3-9824-C018BBF82A14

Q33953399-385C33EA-574A-4125-AAFF-A38DE447A263

Q33953399-44ABE07B-2FBA-4843-8BEF-ECF26EF9D828

Q33953399-5EA4D5BA-26F5-4D10-BD4C-FDEACD7337B9

Q33953399-614C2C02-0E3C-4644-80D9-C37C6497BFA9

Q33953399-71D59A68-2925-4964-BF4A-BD156AED6375

P304

Q33953399-85CB2183-B69A-4279-BFB8-A5A66A88C660

P31

Q33953399-2D11D3D7-1C22-4CB3-85F1-422383326D64

P356

Q33953399-61B68885-7349-4754-8BD1-CE80210EEE9E

P407

Q33953399-7A544BD7-51F4-47E6-8CAD-D3B116261ABB

P433

Q33953399-C6B662AD-0EF5-4D0D-93CA-2D10ED337833

P478

Q33953399-99A00254-3EBC-4096-A752-9B0166C02A11

P577

Q33953399-9167867B-DAD9-4B5C-994B-2F526FF1CB05

P5875

Q33953399-590DD8BE-8B67-429D-A765-7BD250A4F4E9

P698

Q33953399-E149C864-CC2B-4582-A8C2-0B9F9F061DB1

P921

Q33953399-0D815C3D-C7C9-4BA6-BBA9-D70E48B1E4DC

P932

Q33953399-564C811B-89A2-401C-86B7-A70C42A4FA0E

P356

PNAS.1004097107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Injectable hydrogel properties ...... r remodeling in an ovine model

@en

P2093

Elena Tous

http://www.w3.org/2001/XMLSchema#string

J Daniel Robb

http://www.w3.org/2001/XMLSchema#string

Jamie L Ifkovits

http://www.w3.org/2001/XMLSchema#string

Jason A Burdick

http://www.w3.org/2001/XMLSchema#string

Joseph H Gorman

http://www.w3.org/2001/XMLSchema#string

Kevin J Koomalsingh

http://www.w3.org/2001/XMLSchema#string

Masahito Minakawa

http://www.w3.org/2001/XMLSchema#string

Masato Morita

http://www.w3.org/2001/XMLSchema#string

Robert C Gorman

http://www.w3.org/2001/XMLSchema#string

P2860

MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions.

Mechanisms and models in heart failure: A combinatorial approach.

Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium

Dermal filler injection: a novel approach for limiting infarct expansion.

Theoretic impact of infarct compliance on left ventricular function.

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

The potential role of ventricular compressive therapy.

Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs.

Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy.

Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts.

P304

11507-11512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1004097107

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44660138

http://www.w3.org/2001/XMLSchema#string

P698

20534527

http://www.w3.org/2001/XMLSchema#string

P921

P932

2895138

http://www.w3.org/2001/XMLSchema#string